Kenneth Honn

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tang Yong; Wang Man-Tzu; Chen Yakun; Yang Dianer; Che Mingxin; Honn Kenneth V; Akers Gregory D; Johnson Stephen R; Nie Daotai
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
Tao Xiao-hua; Shen Jian-gen; Pan Wei-li; Dong Yu-e; Meng Qun; Honn Kenneth V; Jin Rongxian
Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.
Nie Daotai; Guo Yande; Yang Dianer; Tang Yong; Chen Yakun; Wang Man-Tzu; Zacharek Alex; Qiao Yan; Che Mingxin; Honn Kenneth V
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Kenneth Honn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tang Yong; Wang Man-Tzu; Chen Yakun; Yang Dianer; Che Mingxin; Honn Kenneth V; Akers Gregory D; Johnson Stephen R; Nie Daotai
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
International journal of cancer. Journal international du cancer 2009;124(7):1545-51.
2008: Tao Xiao-hua; Shen Jian-gen; Pan Wei-li; Dong Yu-e; Meng Qun; Honn Kenneth V; Jin Rongxian
Significance of SHP-1 and SHP-2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer.
Pathology oncology research : POR 2008;14(4):365-71.
2008: Nie Daotai; Guo Yande; Yang Dianer; Tang Yong; Chen Yakun; Wang Man-Tzu; Zacharek Alex; Qiao Yan; Che Mingxin; Honn Kenneth V
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
Cancer research 2008;68(1):115-21.
2008: Krishnamoorthy Sriram; Honn Kenneth V
Eicosanoids in tumor progression and metastasis.
Sub-cellular biochemistry 2008;49():145-68.
2007: Pidgeon Graham P; Lysaght Joanne; Krishnamoorthy Sriram; Reynolds John V; O'Byrne Ken; Nie Daotai; Honn Kenneth V
Lipoxygenase metabolism: roles in tumor progression and survival.
Cancer metastasis reviews 2007;26(3-4):503-24.
2007: Wang Man-Tzu; Honn Kenneth V; Nie Daotai
Cyclooxygenases, prostanoids, and tumor progression.
Cancer metastasis reviews 2007;26(3-4):525-34.
2007: Jin Rongxian; Trikha Mohit; Cai Yinlong; Grignon David; Honn Kenneth V
A naturally occurring truncated beta3 integrin in tumor cells: native anti-integrin involved in tumor cell motility.
Cancer biology & therapy 2007;6(10):1559-68.
2006: Krishnamoorthy Sriram; Honn Kenneth V
Inflammation and disease progression.
Cancer metastasis reviews 2006;25(3):481-91.
2006: Nie Daotai; Krishnamoorthy Sriram; Jin Rongxian; Tang Keqin; Chen YuChyu; Qiao Yan; Zacharek Alex; Guo Yande; Milanini Julie; Pages Gilles; Honn Kenneth V
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.
The Journal of biological chemistry 2006;281(27):18601-9.
2005: Döme Balázs; Rásó Erzsébet; Dobos Judit; Mészáros Livia; Varga Norbert; Puskás László G; Fehér Liliána Z; Lörincz Tamár; Ladányi Andrea; Trikha Mohit; Honn Kenneth V; Tímár József
Parallel expression of alphaIIbbeta3 and alphavbeta3 integrins in human melanoma cells upregulates bFGF expression and promotes their angiogenic phenotype.
International journal of cancer. Journal international du cancer 2005;116(1):27-35.
2004: Rásó Erzsébet; Döme Balázs; Somlai Beáta; Zacharek Alex; Hagmann Wolfgang; Honn Kenneth V; Tímár József
Molecular identification, localization and function of platelet-type 12-lipoxygenase in human melanoma progression, under experimental and clinical conditions.
Melanoma research 2004;14(4):245-50.
2004: Nie Daotai; Honn Kenneth V
Eicosanoid regulation of angiogenesis in tumors.
Seminars in thrombosis and hemostasis 2004;30(1):119-25.
2004: Nie Daotai; Che Mingxin; Zacharek Alex; Qiao Yan; Li Li; Li Xinglin; Lamberti Mario; Tang Keqin; Cai Yilong; Guo Yande; Grignon David; Honn Kenneth V
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility.
The American journal of pathology 2004;164(2):429-39.
2003: Kandouz Mustapha; Nie Daotai; Pidgeon Graham P; Krishnamoorthy Sriram; Maddipati Krishna Rao; Honn Kenneth V
Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells.
Prostaglandins & other lipid mediators 2003;71(3-4):189-204.
2003: Pidgeon Graham P; Tang Keqin; Cai Yin Long; Piasentin Evano; Honn Kenneth V
Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression.
Cancer research 2003;63(14):4258-67.
2003: Pidgeon Graham P; Tang Keqin; Rice Renee L; Zacharek Alex; Li Li; Taylor John D; Honn Kenneth V
Overexpression of leukocyte-type 12-lipoxygenase promotes W256 tumor cell survival by enhancing alphavbeta5 expression.
International journal of cancer. Journal international du cancer 2003;105(4):459-71.
2003: Nie Daotai; Nemeth Jeffrey; Qiao Yan; Zacharek Alex; Li Li; Hanna Kenny; Tang Keqin; Hillman Gilda G; Cher Michael L; Grignon David J; Honn Kenneth V
Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase.
Clinical & experimental metastasis 2003;20(7):657-63.
2002: Trikha Mohit; Timar Jozsef; Zacharek Alex; Nemeth Jeffrey A; Cai Yinlong; Dome Balazs; Somlai Beata; Raso Elisabeth; Ladanyi Andrea; Honn Kenneth V
Role for beta3 integrins in human melanoma growth and survival.
International journal of cancer. Journal international du cancer 2002;101(2):156-67.
2002: Nie D; Honn K V
Cyclooxygenase, lipoxygenase and tumor angiogenesis.
Cellular and molecular life sciences : CMLS 2002;59(5):799-807.
2002: Pidgeon Graham P; Kandouz Mustapha; Meram Anthony; Honn Kenneth V
Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
Cancer research 2002;62(9):2721-7.
2002: Kandouz Mustapha; Honn Kenneth V
Eicosanoids regulation of transcription factors in PC-3 prostate cancer cells.
Advances in experimental medicine and biology 2002;507():563-8.
2002: Szekeres Charles K; Trikha Mohit; Honn Kenneth V
12(S)-HETE, pleiotropic functions, multiple signaling pathways.
Advances in experimental medicine and biology 2002;507():509-15.
2001: Rásó E; Tóvári J; Tóth K; Paku S; Trikha M; Honn K V; Tímár J
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells.
Thrombosis and haemostasis 2001;85(6):1037-42.
2001: Nie D; Che M; Grignon D; Tang K; Honn K V
Role of eicosanoids in prostate cancer progression.
Cancer metastasis reviews 2001;20(3-4):195-206.
2000: Szekeres C K; Tang K; Trikha M; Honn K V
Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells.
The Journal of biological chemistry 2000;275(49):38831-41.
2000: Szekeres C K; Trikha M; Nie D; Honn K V
Eicosanoid 12(S)-HETE activates phosphatidylinositol 3-kinase.
Biochemical and biophysical research communications 2000;275(2):690-5.
2000: Timár J; Rásó E; Döme B; Li L; Grignon D; Nie D; Honn K V; Hagmann W
Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential.
International journal of cancer. Journal international du cancer 2000;87(1):37-43.
2000: Nie D; Tang K; Szekeres K; Li L; Honn K V
Eicosanoid regulation of angiogenesis in human prostate carcinoma and its therapeutic implications.
Annals of the New York Academy of Sciences 2000;905():165-76.
2000: Nie D; Tang K; Diglio C; Honn K V
Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase.
Blood 2000;95(7):2304-11.
2000: Tang K; Finley R L; Nie D; Honn K V
Identification of 12-lipoxygenase interaction with cellular proteins by yeast two-hybrid screening.
Biochemistry 2000;39(12):3185-91.
2000: Nie D; Lamberti M; Zacharek A; Li L; Szekeres K; Tang K; Chen Y; Honn K V
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis.
Biochemical and biophysical research communications 2000;267(1):245-51.
2000: Nie D; Tang K; Szekeres K; Trikha M; Honn K V
The role of eicosanoids in tumor growth and metastasis.
Ernst Schering Research Foundation workshop 2000;(31):201-17.
1999: Tang K; Nie D; Cai Y; Honn K V
The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway.
Biochemical and biophysical research communications 1999;264(1):127-32.
1999: Li L; Zhu Z; Joshi B; Zhang C; Johnson C R; Marnett L J; Honn K V; Crissman J D; Porter A T; Tang D G
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies.
Anticancer research 1999;19(1A):61-9.
1999: Nie D; Hillman G G; Geddes T; Tang K; Pierson C; Grignon D J; Honn K V
Platelet-type 12-lipoxygenase regulates angiogenesis in human prostate carcinoma.
Advances in experimental medicine and biology 1999;469():623-30.
1999: Timár J; Rásó E; Honn K V; Hagmann W
12-lipoxygenase expression in human melanoma cell lines.
Advances in experimental medicine and biology 1999;469():617-22.
1999: Tang K; Nie D; Honn K V
Role of autocrine motility factor in a 12-lipoxygenase dependent anti-apoptotic pathway.
Advances in experimental medicine and biology 1999;469():583-90.
1999: Tang K; Honn K V
12(S)-HETE in cancer metastasis.
Advances in experimental medicine and biology 1999;447():181-91.
1998: Trikha M; Cai Y; Grignon D; Honn K V
Identification of a novel truncated alphaIIb integrin.
Cancer research 1998;58(21):4771-5.
1998: Nie D; Hillman G G; Geddes T; Tang K; Pierson C; Grignon D J; Honn K V
Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth.
Cancer research 1998;58(18):4047-51.
1998: Timar J; Trikha M; Szekeres K; Bazaz R; Honn K
Expression and function of the high affinity alphaIIbbeta3 integrin in murine melanoma cells.
Clinical & experimental metastasis 1998;16(5):437-45.
1998: Rice R L; Tang D G; Haddad M; Honn K V; Taylor J D
12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process.
International journal of cancer. Journal international du cancer 1998;77(2):271-8.
1998: Trikha M; Raso E; Cai Y; Fazakas Z; Paku S; Porter A T; Timar J; Honn K V
Role of alphaII(b)beta3 integrin in prostate cancer metastasis.
The Prostate 1998;35(3):185-92.
1998: Tang D G; Li L; Zhu Z; Joshi B; Johnson C R; Marnett L J; Honn K V; Crissman J D; Krajewski S; Reed J C; Timar J; Porter A T
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases.
Pathology oncology research : POR 1998;4(3):179-90.
1997: Tang D G; Guan K L; Li L; Honn K V; Chen Y Q; Rice R L; Taylor J D; Porter A T
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids.
International journal of cancer. Journal international du cancer 1997;72(6):1078-87.
1997: Chen Y Q; Trikha M; Gao X; Bazaz R; Porter A T; Timar J; Honn K V
Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin.
International journal of cancer. Journal international du cancer 1997;72(4):642-8.
1997: Tang D G; Honn K V
Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by NDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumor cell survival.
Journal of cellular physiology 1997;172(2):155-70.
1997: Trikha M; Timar J; Lundy S K; Szekeres K; Cai Y; Porter A T; Honn K V
The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells.
Cancer research 1997;57(12):2522-8.
1997: Gao X; Porter A T; Grignon D J; Pontes J E; Honn K V
Diagnostic and prognostic markers for human prostate cancer.
The Prostate 1997;31(4):264-81.
1997: Honn K V; Tang D G
Eicosanoid 12(S)-HETE upregulates endothelial cell alpha V beta 3 integrin expression and promotes tumor cell adhesion to vascular endothelium.
Advances in experimental medicine and biology 1997;400B():765-73.
1997: Timar J; Bazaz R; Tang D G; Kimler V; Taylor J D; Honn K V
Post-translational regulation of surface integrin expression in tumor cells by 12(S)-HETE.
Advances in experimental medicine and biology 1997;400B():757-63.
1997: Liu B; Maher R J; De Jonckheere J P; Popat R U; Stojakovic S; Hannun Y A; Porter A T; Honn K V
12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha.
Advances in experimental medicine and biology 1997;400B():707-18.
1997: Silletti S; Timar J; Honn K V; Raz A
Regulation of tumor cell motility by 12(S)-HETE.
Advances in experimental medicine and biology 1997;400B():683-92.
1997: Gao X; Hagmann W; Zacharek A; Wu N; Lee M; Porter A T; Honn K V
Eicosanoids, cancer metastasis, and gene regulation: an overview.
Advances in experimental medicine and biology 1997;400A():545-55.
1997: Tang D G; Honn K V
Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization.
Advances in experimental medicine and biology 1997;400A():349-61.
1997: Chen Y Q; Hagmann W; Honn K V
Regulation of 12(S)-HETE production in tumor cells.
Advances in experimental medicine and biology 1997;400A():159-66.
1997: Hagmann W; Maher R; Honn K V
Intracellular distribution, activity, and Ca(2+)-dependent translocation of 12-lipoxygenase in Lewis lung tumor cells.
Advances in experimental medicine and biology 1997;400A():57-64.
1997: Tang K; Honn K V
Lipoxygenase metabolites and cancer metastasis.
Advances in experimental medicine and biology 1997;422():71-84.
1997: Tang D G; Porter A T; Honn K V
Critical role of arachidonate lipoxygenases in regulating apoptosis.
Advances in experimental medicine and biology 1997;407():405-11.
1997: Tímár J; Tóvári J; Szekeres K; Kagawa D; Honn K V
Key determinants of the invasion mechanism of melanoma. Role for a new signaling pathway.
Advances in experimental medicine and biology 1997;407():303-10.
1997: Trikha M; Honn K V
Role of 12-lipoxygenase and protein kinase C in modulating the activation state of the integrin alpha IIb beta 3 on human tumor cells.
Advances in experimental medicine and biology 1997;407():55-60.
1997: Gao X; Porter A T; Honn K V
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Advances in experimental medicine and biology 1997;407():41-53.
1996: Tímár J; Rásó E; Fazakas Z S; Silletti S; Raz A; Honn K V
Multiple use of a signal transduction pathway in tumor cell invasion.
Anticancer research 1996;16(6A):3299-306.
1996: Hagmann W; Gao X; Timar J; Chen Y Q; Strohmaier A R; Fahrenkopf C; Kagawa D; Lee M; Zacharek A; Honn K V
12-Lipoxygenase in A431 cells: genetic identity, modulation of expression, and intracellular localization.
Experimental cell research 1996;228(2):197-205.
1996: Trikha M; Timar J; Lundy S K; Szekeres K; Tang K; Grignon D; Porter A T; Honn K V
Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin.
Cancer research 1996;56(21):5071-8.
1996: Tang D G; Chen Y Q; Honn K V
Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(11):5241-6.
1996: Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn K V
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Cancer research 1996;56(8):1902-8.
1996: Honn K V; Aref A; Chen Y Q; Cher M L; Crissman J D; Forman J D; Gao X; Grignon D; Hussain M; Porter A T; Pontes J E; Powell I; Redman B; Sakr W; Severson R; Tang D G; Wood D P
Prostate cancer old problems and new approaches : Part I. epidemiology, incidence and genetic alterations.
Pathology oncology research : POR 1996;2(1-2):98-109.
1996: Timar J; Liu B; Bazaz R; Honn K V
Association of protein kinase-C-alpha with cytoplasmic vesicles in melanoma cells.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1996;44(2):177-82.
1996: Tang D G; Honn K V
Adhesion molecules and tumor cell-vasculature interactions: modulation by bioactive lipid molecules.
Current topics in microbiology and immunology 1996;213 ( Pt 2)():69-88.
1995: Tang D G; Tarrien M; Dobrzynski P; Honn K V
Melanoma cell spreading on fibronectin induced by 12(S)-HETE involves both protein kinase C- and protein tyrosine kinase-dependent focal adhesion formation and tyrosine phosphorylation of focal adhesion kinase (pp125FAK).
Journal of cellular physiology 1995;165(2):291-306.
1995: Gao X; Chen Y Q; Wu N; Grignon D J; Sakr W; Porter A T; Honn K V
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Oncogene 1995;11(7):1395-8.
1995: Gao X; Zacharek A; Grignon D J; Sakr W; Powell I J; Porter A T; Honn K V
Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
Oncogene 1995;11(7):1241-7.
1995: Liu B; Khan W A; Hannun Y A; Timar J; Taylor J D; Lundy S; Butovich I; Honn K V
12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(20):9323-7.
1995: Tang D G; Diglio C A; Bazaz R; Honn K V
Transcriptional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE.
Journal of cell science 1995;108 ( Pt 7)():2629-44.
1995: Tímár J; Bazaz R; Kimler V; Haddad M; Tang D G; Robertson D; Tovari J; Taylor J D; Honn K V
Immunomorphological characterization and effects of 12-(S)-HETE on a dynamic intracellular pool of the alpha IIb beta 3-integrin in melanoma cells.
Journal of cell science 1995;108 ( Pt 6)():2175-86.
1995: Tang D G; Renaud C; Stojakovic S; Diglio C A; Porter A; Honn K V
12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis.
Biochemical and biophysical research communications 1995;211(2):462-8.
1995: Gao X; Zacharek A; Salkowski A; Grignon D J; Sakr W; Porter A T; Honn K V
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer.
Cancer research 1995;55(5):1002-5.
1995: Wojtukiewicz M Z; Tang D G; Ben-Josef E; Renaud C; Walz D A; Honn K V
Solid tumor cells express functional "tethered ligand" thrombin receptor.
Cancer research 1995;55(3):698-704.
1995: Hagmann W; Gao X; Zacharek A; Wojciechowski L A; Honn K V
12-Lipoxygenase in Lewis lung carcinoma cells: molecular identity, intracellular distribution of activity and protein, and Ca(2+)-dependent translocation from cytosol to membranes.
Prostaglandins 1995;49(1):49-62.
1995: Tang D G; Grossi I M; Tang K Q; Diglio C A; Honn K V
Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: rationale for their antimetastatic effects.
International journal of cancer. Journal international du cancer 1995;60(3):418-25.
1995: Gao X; Honn K V
Biological properties of 12(S)-HETE in cancer metastasis.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():439-44.
1994: Onoda J M; Kantak S S; Piechocki M P; Awad W; Chea R; Liu B; Honn K V
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor.
Radiation research 1994;140(3):410-8.
1994: Honn K V; Tang D G; Gao X; Butovich I A; Liu B; Timar J; Hagmann W
12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.
Cancer metastasis reviews 1994;13(3-4):365-96.
1994: Schneider M R; Tang D G; Schirner M; Honn K V
Prostacyclin and its analogues: antimetastatic effects and mechanisms of action.
Cancer metastasis reviews 1994;13(3-4):349-64.
1994: Marnett L J; Honn K V
Overview of articles on eicosanoids and cancer.
Cancer metastasis reviews 1994;13(3-4):237-9.
1994: Silletti S; Timar J; Honn K V; Raz A
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Cancer research 1994;54(22):5752-6.
1994: Tang D G; Honn K V
12-Lipoxygenase, 12(S)-HETE, and cancer metastasis.
Annals of the New York Academy of Sciences 1994;744():199-215.
1994: Honn K V; Timár J; Rozhin J; Bazaz R; Sameni M; Ziegler G; Sloane B F
A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
Experimental cell research 1994;214(1):120-30.
1994: Liu B; Maher R J; Hannun Y A; Porter A T; Honn K V
12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha.
Journal of the National Cancer Institute 1994;86(15):1145-51.
1994: Liu B; Marnett L J; Chaudhary A; Ji C; Blair I A; Johnson C R; Diglio C A; Honn K V
Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
Laboratory investigation; a journal of technical methods and pathology 1994;70(3):314-23.
1994: Chen Y Q; Duniec Z M; Liu B; Hagmann W; Gao X; Shimoji K; Marnett L J; Johnson C R; Honn K V
Endogenous 12(S)-HETE production by tumor cells and its role in metastasis.
Cancer research 1994;54(6):1574-9.
1994: Tang D G; Diglio C A; Honn K V
Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
Cancer research 1994;54(4):1119-29.
1994: Honn K V; Tang D G; Grossi I; Duniec Z M; Timar J; Renaud C; Leithauser M; Blair I; Johnson C R; Diglio C A
Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
Cancer research 1994;54(2):565-74.
1994: Honn K V; Tang D G; Grossi I M; Renaud C; Duniec Z M; Johnson C R; Diglio C A
Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis.
Experimental cell research 1994;210(1):1-9.
1994: Tang D G; Honn K V
Adhesion molecules and tumor metastasis: an update.
Invasion & metastasis 1994;14(1-6):109-22.
1993: Hagmann W; Kagawa D; Renaud C; Honn K V
Activity and protein distribution of 12-lipoxygenase in HEL cells: induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca(2+)-dependent translocation to membranes.
Prostaglandins 1993;46(6):471-7.
1993: Timar J; Silletti S; Bazaz R; Raz A; Honn K V
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
International journal of cancer. Journal international du cancer 1993;55(6):1003-10.
1993: Tang D G; Chen Y Q; Newman P J; Shi L; Gao X; Diglio C A; Honn K V
Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium.
The Journal of biological chemistry 1993;268(30):22883-94.
1993: Tang D G; Timar J; Grossi I M; Renaud C; Kimler V A; Diglio C A; Taylor J D; Honn K V
The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells.
Experimental cell research 1993;207(2):361-75.
1993: Wojtukiewicz M Z; Tang D G; Ciarelli J J; Nelson K K; Walz D A; Diglio C A; Mammen E F; Honn K V
Thrombin increases the metastatic potential of tumor cells.
International journal of cancer. Journal international du cancer 1993;54(5):793-806.
1993: Gao X; Honn K V; Grignon D; Sakr W; Chen Y Q
Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
Cancer research 1993;53(12):2723-7.
1993: Tang D G; Chen Y Q; Diglio C A; Honn K V
Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor.
The Journal of cell biology 1993;121(3):689-704.
1993: Tang D G; Onoda J M; Steinert B W; Grossi I M; Nelson K K; Umbarger L; Diglio C A; Taylor J D; Honn K V
Phenotypic properties of cultured tumor cells: integrin alpha IIb beta 3 expression, tumor-cell-induced platelet aggregation, and tumor-cell adhesion to endothelium as important parameters of experimental metastasis.
International journal of cancer. Journal international du cancer 1993;54(2):338-47.
1993: Steinert B W; Tang D G; Grossi I M; Umbarger L A; Honn K V
Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation.
International journal of cancer. Journal international du cancer 1993;54(1):92-101.
1993: Tang D G; Grossi I M; Chen Y Q; Diglio C A; Honn K V
12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cells.
International journal of cancer. Journal international du cancer 1993;54(1):102-11.
1993: Tang D G; Diglio C A; Honn K V
12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and alpha V beta 3 integrins.
Prostaglandins 1993;45(3):249-67.
1993: Timar J; Tang D; Bazaz R; Haddad M M; Kimler V A; Taylor J D; Honn K V
PKC mediates 12(S)-HETE-induced cytoskeletal rearrangement in B16a melanoma cells.
Cell motility and the cytoskeleton 1993;26(1):49-65.
1992: Honn K V; Nelson K K; Renaud C; Bazaz R; Diglio C A; Timar J
Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis.
Prostaglandins 1992;44(5):413-29.
1992: Chen Y Q; Liu B; Tang D G; Honn K V
Fatty acid modulation of tumor cell-platelet-vessel wall interaction.
Cancer metastasis reviews 1992;11(3-4):389-409.
1992: Honn K V; Tang D G
Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix.
Cancer metastasis reviews 1992;11(3-4):353-75.
1992: Honn K V; Tang D G; Crissman J D
Platelets and cancer metastasis: a causal relationship?
Cancer metastasis reviews 1992;11(3-4):325-51.
1992: Honn K V; Tang D
Hemostasis and malignancy: an overview.
Cancer metastasis reviews 1992;11(3-4):223-6.
1992: Wojtukiewicz M Z; Tang D G; Nelson K K; Walz D A; Diglio C A; Honn K V
Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface.
Thrombosis research 1992;68(3):233-45.
1992: Timar J; Chen Y Q; Liu B; Bazaz R; Taylor J D; Honn K V
The lipoxygenase metabolite 12(S)-HETE promotes alpha IIb beta 3 integrin-mediated tumor-cell spreading on fibronectin.
International journal of cancer. Journal international du cancer 1992;52(4):594-603.
1992: Chen Y Q; Gao X; Timar J; Tang D; Grossi I M; Chelladurai M; Kunicki T J; Fligiel S E; Taylor J D; Honn K V
Identification of the alpha IIb beta 3 integrin in murine tumor cells.
The Journal of biological chemistry 1992;267(24):17314-20.
1992: Liu B; Renaud C; Nelson K K; Chen Y Q; Bazaz R; Kowynia J; Timar J; Diglio C A; Honn K V
Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization.
International journal of cancer. Journal international du cancer 1992;52(1):147-52.
1992: Honn K V; Chen Y Q; Timar J; Onoda J M; Hatfield J S; Fligiel S E; Steinert B W; Diglio C A; Grossi I M; Nelson K K
Alpha IIb beta 3 integrin expression and function in subpopulations of murine tumors.
Experimental cell research 1992;201(1):23-32.
1992: Onoda J M; Piechocki M P; Honn K V
Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: effects on metastatic potential.
Radiation research 1992;130(3):281-8.
1992: Chang Y S; Chen Y Q; Timar J; Nelson K K; Grossi I M; Fitzgerald L A; Diglio C A; Honn K V
Increased expression of alpha IIb beta 3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability.
International journal of cancer. Journal international du cancer 1992;51(3):445-51.
1992: Chopra H; Timar J; Rong X; Grossi I M; Hatfield J S; Fligiel S E; Finch C A; Taylor J D; Honn K V
Is there a role for the tumor cell integrin alpha IIb beta 3 and cytoskeleton in tumor cell-platelet interaction?
Clinical & experimental metastasis 1992;10(2):125-37.
1992: Buck M R; Karustis D G; Day N A; Honn K V; Sloane B F
Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.
The Biochemical journal 1992;282 ( Pt 1)():273-8.
1992: Boike G; Lah T; Sloane B F; Rozhin J; Honn K; Guirguis R; Stracke M L; Liotta L A; Schiffmann E
A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells.
Melanoma research 1992;1(5-6):333-40.
1992: Honn K V; Tang D G; Chen Y Q
Platelets and cancer metastasis: more than an epiphenomenon.
Seminars in thrombosis and hemostasis 1992;18(4):392-415.
1992: Timar J; Chopra H; Rong X; Hatfield J S; Fligiel S E; Onoda J M; Taylor J D; Honn K V
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
Journal of cancer research and clinical oncology 1992;118(6):425-34.
1991: Liu B; Timar J; Howlett J; Diglio C A; Honn K V
Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C.
Cell regulation 1991;2(12):1045-55.
1991: Chopra H; Timar J; Chen Y Q; Rong X H; Grossi I M; Fitzgerald L A; Taylor J D; Honn K V
The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
International journal of cancer. Journal international du cancer 1991;49(5):774-86.
1991: Chelladurai M; Honn K V; Walz D A
HLA-DR is a procoagulant.
Biochemical and biophysical research communications 1991;178(2):467-73.
1991: Chang S Y; Chen Y Q; Fitzgerald L A; Honn K V
Analysis of integrin mRNA in human and rodent tumor cells.
Biochemical and biophysical research communications 1991;176(1):108-13.
1991: Marnett L J; Leithauser M T; Richards K M; Blair I; Honn K V; Yamamoto S; Yoshimoto T
Arachidonic acid metabolism of cytosolic fractions of Lewis lung carcinoma cells.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():895-900.
1990: Chopra H; Fligiel S E; Hatfield J S; Nelson K K; Diglio C A; Taylor J D; Honn K V
An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions.
Cancer research 1990;50(23):7686-96.
1990: Rozhin J; Gomez A P; Ziegler G H; Nelson K K; Chang Y S; Fong D; Onoda J M; Honn K V; Sloane B F
Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
Cancer research 1990;50(19):6278-84.
1990: Sloane B F; Rozhin J; Robinson D; Honn K V
Role for cathepsin B and cystatins in tumor growth and progression.
Biological chemistry Hoppe-Seyler 1990;371 Suppl():193-8.
1990: Onoda J M; Nelson K K; Pilarski S M; White N S; Mihu R G; Honn K V
Combination chemotherapy with cisplatin and nifedipine: synergistic antitumor effects against a cisplatin-resistant subline of the B16 amelanotic melanoma.
Clinical & experimental metastasis 1990;8(1):59-73.
1989: Lah T T; Clifford J L; Helmer K M; Day N A; Moin K; Honn K V; Crissman J D; Sloane B F
Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.
Biochimica et biophysica acta 1989;993(1):63-73.
1989: Rozhin J; Wade R L; Honn K V; Sloane B F
Membrane-associated cathepsin L: a role in metastasis of melanomas.
Biochemical and biophysical research communications 1989;164(1):556-61.
1989: Honn K V; Grossi I M; Diglio C A; Wojtukiewicz M; Taylor J D
Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1989;3(11):2285-93.
1989: Lah T T; Buck M R; Honn K V; Crissman J D; Rao N C; Liotta L A; Sloane B F
Degradation of laminin by human tumor cathepsin B.
Clinical & experimental metastasis 1989;7(4):461-8.
1989: Onoda J M; Nelson K K; Taylor J D; Honn K V
In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
Cancer research 1989;49(11):2844-50.
1989: Weiss L; Orr F W; Honn K V
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.
Clinical & experimental metastasis 1989;7(2):127-67.
1989: Moin K; Rozhin J; McKernan T B; Sanders V J; Fong D; Honn K V; Sloane B F
Enhanced levels of cathepsin B mRNA in murine tumors.
FEBS letters 1989;244(1):61-4.
1989: Grossi I M; Fitzgerald L A; Umbarger L A; Nelson K K; Diglio C A; Taylor J D; Honn K V
Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid.
Cancer research 1989;49(4):1029-37.
1989: Honn K V; Grossi I M; Steinert B W; Chopra H; Onoda J; Nelson K K; Taylor J D
Lipoxygenase regulation of membrane expression of tumor cell glycoproteins and subsequent metastasis.
Advances in prostaglandin, thromboxane, and leukotriene research 1989;19():439-43.
1988: Honn K V; Grossi I M; Fitzgerald L A; Umbarger L A; Diglio C A; Taylor J D
Lipoxygenase products regulate IRGpIIb/IIIa receptor mediated adhesion of tumor cells to endothelial cells, subendothelial matrix and fibronectin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1988;189(1):130-5.
1988: Crissman J D; Hatfield J S; Menter D G; Sloane B; Honn K V
Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix.
Cancer research 1988;48(14):4065-72.
1988: Chopra H; Hatfield J S; Chang Y S; Grossi I M; Fitzgerald L A; O'Gara C Y; Marnett L J; Diglio C A; Taylor J D; Honn K V
Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation.
Cancer research 1988;48(13):3787-800.
1988: Onoda J M; Nelson K K; Taylor J D; Honn K V
Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor.
Cancer letters 1988;40(1):39-47.
1988: Grossi I M; Hatfield J S; Fitzgerald L A; Newcombe M; Taylor J D; Honn K V
Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1988;2(8):2385-95.
1988: Onoda J M; Nelson K K; Grossi I M; Umbarger L A; Taylor J D; Honn K V
Separation of high and low metastatic subpopulations from solid tumors by centrifugal elutriation.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1988;187(2):250-5.
1988: Weiss L; Orr F W; Honn K V
Interactions of cancer cells with the microvasculature during metastasis.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1988;2(1):12-21.
1988: Sloane B F; Rozhin J; Lah T T; Day N A; Buck M; Ryan R E; Crissman J D; Honn K V
Tumor cathepsin B and its endogenous inhibitors in metastasis.
Advances in experimental medicine and biology 1988;233():259-68.
1988: Cavanaugh P G; Sloane B F; Honn K V
Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis.
Haemostasis 1988;18(1):37-46.
1987: Grossi I M; Fitzgerald L A; Kendall A; Taylor J D; Sloane B F; Honn K V
Inhibition of human tumor cell induced platelet aggregation by antibodies to platelet glycoproteins Ib and IIb/IIIa.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1987;186(3):378-83.
1987: Menter D G; Steinert B W; Sloane B F; Gundlach N; O'Gara C Y; Marnett L J; Diglio C; Walz D; Taylor J D; Honn K V
Role of platelet membrane in enhancement of tumor cell adhesion to endothelial cell extracellular matrix.
Cancer research 1987;47(24 Pt 1):6751-62.
1987: Rozhin J; Robinson D; Stevens M A; Lah T T; Honn K V; Ryan R E; Sloane B F
Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
Cancer research 1987;47(24 Pt 1):6620-8.
1987: Menter D G; Sloane B F; Steinert B W; Onoda J; Craig R; Harkins C; Taylor J D; Honn K V
Platelet enhancement of tumor cell adhesion to subendothelial matrix: role of platelet cytoskeleton and platelet membrane.
Journal of the National Cancer Institute 1987;79(5):1077-90.
1987: Menter D G; Onoda J M; Moilanen D; Sloane B F; Taylor J D; Honn K V
Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
Journal of the National Cancer Institute 1987;78(5):961-9.
1987: Menter D G; Steinert B W; Sloane B F; Taylor J D; Honn K V
A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.
Cancer research 1987;47(9):2425-32.
1987: Honn K V; Steinert B W; Moin K; Onoda J M; Taylor J D; Sloane B F
The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation.
Biochemical and biophysical research communications 1987;145(1):384-9.
1987: Menter D G; Hatfield J S; Harkins C; Sloane B F; Taylor J D; Crissman J D; Honn K V
Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells.
Clinical & experimental metastasis 1987;5(1):65-78.
1987: Honn K V; Steinert B W; Onoda J M; Sloane B F
The role of platelets in metastasis.
Biorheology 1987;24(2):127-37.
1987: Sloane B F; Rozhin J; Hatfield J S; Crissman J D; Honn K V
Plasma membrane-associated cysteine proteinases in human and animal tumors.
Experimental cell biology 1987;55(4):209-24.
1987: Menter D G; Harkins C; Onoda J; Riorden W; Sloane B F; Taylor J D; Honn K V
Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.
Invasion & metastasis 1987;7(2):109-28.
1987: Honn K V; Menter D G; Onoda J M; Steinert B W; Diglio C A; Taylor J D; Sloane B F
Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():981-5.
1986: Sloane B F; Rozhin J; Johnson K; Taylor H; Crissman J D; Honn K V
Cathepsin B: association with plasma membrane in metastatic tumors.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(8):2483-7.
1986: Onoda J M; Jacobs J R; Taylor J D; Sloane B F; Honn K V
Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases.
Cancer letters 1986;30(2):181-8.
1986: Crissman J D; Hatfield J S; Honn K V
Clinical and experimental morphologic parameters predictive of tumor metastasis.
Progress in clinical and biological research 1986;212():251-67.
1986: Honn K V; Onoda J M; Menter D G; Cavanaugh P G; Taylor J D; Crissman J D; Ryan R E; Sloane B F
Possible strategies for antimetastastic therapy.
Progress in clinical and biological research 1986;212():217-49.
1985: Crissman J D; Hatfield J; Schaldenbrand M; Sloane B F; Honn K V
Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study.
Laboratory investigation; a journal of technical methods and pathology 1985;53(4):470-8.
1985: Ryan R E; Crissman J D; Honn K V; Sloane B F
Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
Cancer research 1985;45(8):3636-41.
1985: Honn K V; Marnett L J
Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins.
Biochemical and biophysical research communications 1985;129(1):34-40.
1985: Cavanaugh P G; Sloane B F; Bajkowski A S; Taylor J D; Honn K V
Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity.
Thrombosis research 1985;37(2):309-26.
1985: Honn K V; Onoda J M; Pampalona K; Battaglia M; Neagos G; Taylor J D; Diglio C A; Sloane B F
Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo.
Biochemical pharmacology 1985;34(2):235-41.
1985: Honn K V; Weller P; Marnett L J
Effects of prostaglandins possessing an alpha,beta-unsaturated carbonyl on tumor growth and differentiation.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():411-3.
1984: Samokyszyn V M; Sloane B F; Honn K V; Marnett L J
Cooxidation of 13-cis-retinoic acid by prostaglandin H synthase.
Biochemical and biophysical research communications 1984;124(2):430-6.
1984: Marnett L J; Siedlik P H; Ochs R C; Pagels W R; Das M; Honn K V; Warnock R H; Tainer B E; Eling T E
Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.
Molecular pharmacology 1984;26(2):328-35.
1984: Onoda J M; Sloane B F; Honn K V
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Thrombosis research 1984;34(5):367-78.
1984: Menter D G; Onoda J M; Taylor J D; Honn K V
Effects of prostacyclin on tumor cell-induced platelet aggregation.
Cancer research 1984;44(2):450-6.
1984: Honn K V; Onoda J M; Diglio C A; Carufel M M; Taylor J D; Sloane B F
Inhibition of tumor cell-platelet interactions and tumor metastasis by the calcium channel blocker, nimodipine.
Clinical & experimental metastasis 1984;2(1):61-72.
1984: Sloane B F; Honn K V
Cysteine proteinases and metastasis.
Cancer metastasis reviews 1984;3(3):249-63.
1983: Krug E C; Honn K V; Battista J; Nicoll C S
Corticosteroids in serum of Rana catesbeiana during development and metamorphosis.
General and comparative endocrinology 1983;52(2):232-41.
1983: Honn K V; Onoda J M; Diglio C A; Sloane B F
Calcium channel blockers: potential antimetastatic agents.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1983;174(1):16-9.
1983: Cavanaugh P G; Sloane B F; Bajkowski A S; Gasic G J; Gasic T B; Honn K V
Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles.
Clinical & experimental metastasis 1983;1(4):297-307.
1983: Honn K V
Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system.
Clinical & experimental metastasis 1983;1(2):103-14.
1983: Honn K V; Busse W D; Sloane B F
Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis.
Biochemical pharmacology 1983;32(1):1-11.
1983: Honn K V; Menter D; Cavanaugh P G; Neagos G; Moilanen D; Taylor J D; Sloane B F
A review of prostaglandins and the treatment of tumor metastasis.
Acta clinica Belgica 1983;38(1):53-67.
1983: Honn K V; Menter D G; Onoda J M; Taylor J D; Sloane B F
Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
Symposium on Fundamental Cancer Research 1983;36():361-88.
1983: Honn K V; Sloane B F
Prostacyclin, thromboxanes, and hematogenous metastasis.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;12():313-8.
1982: Honn K V; Cavanaugh P; Evens C; Taylor J D; Sloane B F
Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin.
Science (New York, N.Y.) 1982;217(4559):540-2.
1982: Sloane B F; Honn K V; Sadler J G; Turner W A; Kimpson J J; Taylor J D
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
Cancer research 1982;42(3):980-6.
1982: Honn K V; Dunn J R
Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation.
FEBS letters 1982;139(1):65-8.
1982: Honn K V; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
Progress in clinical and biological research 1982;89():295-331.
1981: Honn K V; Meyer J
Thromboxanes and prostacyclin: positive and negative modulators of tumor growth.
Biochemical and biophysical research communications 1981;102(4):1122-9.
1981: Sloane B F; Dunn J R; Honn K V
Lysosomal cathepsin B: correlation with metastatic potential.
Science (New York, N.Y.) 1981;212(4499):1151-3.
1981: Honn K V; Cicone B; Skoff A
Prostacyclin: a potent antimetastatic agent.
Science (New York, N.Y.) 1981;212(4500):1270-2.
1981: Honn K V; Bockman R S; Marnett L J
Prostaglandins and cancer: a review of tumor initiation through tumor metastasis.
Prostaglandins 1981;21(5):833-64.
1981: Honn K V; Romine M; Skoff A
Prostaglandin analogs as inhibitors of tumor cell DNA synthesis.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1981;166(4):562-7.
1980: Battista J R; Honn K V
The effect of prostaglandins on 11-beta hydroxylase activity in bovine adrenocortical mitochondria.
Biochemical and biophysical research communications 1980;93(4):1104-9.
1979: Honn K V; Dunn J R; Morgan L R; Bienkowski M; Marnett L J
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.
Biochemical and biophysical research communications 1979;87(3):795-801.
1978: Chavin W; Honn K V; Clifford P J
Prostaglandin effects upon cyclic AMP levels, corticosterone output, and aldosterone output in the adrenal of the frog, Rana berlandieri forreri.
General and comparative endocrinology 1978;36(4):442-50.
1978: Honn K V; Chavin W
In vitro tropic action of ACTH upon adrenocortical cyclic nucleotide (cAMP, cGMP) production and corticosterone output in blue (Prionace glauca Linnaeus) and in mako (Isurus oxyrinchus Rafinesque) sharks.
General and comparative endocrinology 1978;36(1):161-9.
1978: Chavin W; Honn K V; Clifford P J
cAMP involvement in the control of corticosterone and aldosterone output in the adrenal of the frog (Rana berlandieri forreri)
General and comparative endocrinology 1978;35(4):445-50.
1978: Honn K V; Chavin W
In vitro effects of theophylline and aminogluthetimide upon basal and ACTH induced cAMP levels and steroid output by the normal human adrenal gland.
Acta endocrinologica 1978;88(2):354-63.
1978: Honn K V; Chavin W
Temporal effect of prostaglandins E and F on human adrenal cAMP and cortisol output.
Life sciences 1978;22(7):543-52.
1977: Honn K V; Chavin W; Singhakowinta A
In vitro responses of focal hyperplastic tissue of the human adrenal zona fasciculata to ACTH.
Acta endocrinologica 1977;86(2):363-8.
1977: Honn K V; Chavin W
In vitro cAMP, aldosterone and cortisol responses of adult human adrenocortical tissue to ACTH and human growth hormone.
Experientia 1977;33(9):1237-8.
1977: Honn K V; Chavin W
In vitro temporal cAMP and cortisol responses to ACTH by the normal human adrenal gland.
Acta endocrinologica 1977;85(4):823-31.
1977: Honn K V; Chavin W
In vitro ACTH stimulation of corticosterone output in relation to cyclic nucleotide alterations in the crocodilian (Caiman sclerops) adrenal.
General and comparative endocrinology 1977;32(3):330-40.
1977: Honn K V; Chavin W
Effects of A and B prostaglandins on cAMP, cortisol, and aldosterone production by the human adrenal.
Biochemical and biophysical research communications 1977;76(4):977-82.
1977: Honn K V; Chavin W
Temporal effects of ACTH, indomethacin and 7-oxa-13-prostynoic acid upon glucocorticoid production by the human adrenal.
Experientia 1977;33(4):545-6.
1977: deAlvare L R; Kimura T; Singhakowinta A; Honn K V; Chavin W
Mitochondrial redox components of human adrenocortical steroid hydroxylases under physiological conditions and in focal hyperplasia of the zone fasciculata.
Acta endocrinologica 1977;84(4):780-8.
1977: Honn K V; Chavin W
Antagonistic action of E and F series prostaglandins upon mineralocorticoid production by the human adrenal.
Experientia 1977;33(3):398-400.
1976: Honn K V; Chavin W
Prostaglandin modulation of the mechanism of ACTH action in the human adrenal.
Biochemical and biophysical research communications 1976;73(1):164-70.
1976: Honn K V; Chavin W
Role of prostaglandins in aldosterone production by the human adrenal.
Biochemical and biophysical research communications 1976;72(4):1319-26.
1976: Honn K V; Chavin W
In vitro trophic action of ACTH and insulin upon adrenocortical enzymes of the squaliform elasmobranch Ginglymostoma cirratum (Bonnaterre).
General and comparative endocrinology 1976;29(3):360-8.
1976: Kimura T; Wang H P; de Alvare L R; Honn K V; Chavin W
Cytochrome P-450 and adrenodoxin in adrenal mitochondrial fractions of several lower vertebrates.
Comparative biochemistry and physiology. B, Comparative biochemistry 1976;53(3):273-6.
1975: Taylor J D; Honn K V; Chavin W
Adrenocortical ultrastructure in the squaliform elasmobranch (Ginglymostoma cirratum Bonnaterre): cell death, a postulate for holocrine secretion.
General and comparative endocrinology 1975;27(3):358-70.
1975: Honn K V; Chavin W
An improved automated Biuret method for the determination of microgram protein concentrations.
Analytical biochemistry 1975;68(1):230-5.
1975: Honn K V; Singley J A; Chavin W
Fetal bovine serum: a multivariate standard.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1975;149(2):344-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Kenneth Honn

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Anatomy

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Kenneth Honn (preview)

All Publications